Skip to content

Clinical trials

Genetic Diseases, Inborn trials in India

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Genetic Diseases, Inborn Country / region: India Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20092
20173
20185
20211
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting2
Withdrawn2
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
CENTOGENE GmbH Rostock2
Genzyme, a Sanofi Company2
Quince Therapeutics S.p.A.2
Regeneron Pharmaceuticals2
Forma Therapeutics, Inc.1
Friedreich's Ataxia Research Alliance1
JCR Pharmaceuticals Co., Ltd.1
PTC Therapeutics1
Sumitomo Pharma Switzerland GmbH1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Genetic Diseases, Inborn13
Metabolism, Inborn Errors5
Lysosomal Storage Diseases4
Metabolic Diseases4
Musculoskeletal Diseases4
Genetic Diseases, X-Linked3
Hematologic Diseases3
Arthritis2
Blood Coagulation Disorders2
Blood Coagulation Disorders, Inherited2

Trials

Showing 51 to 13 of 13. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.